Wholesale of pharmaceutical and medical goods
ORIFARM NORWAY AS
Revenue 2024
NOK 142.0m
Operating profit
NOK −1.8bn
Equity
NOK 9.3bn
Incorporated
2020
Share capital
NOK 30,000
Varemerker (4)
| Name | Application no. | Reg. no. | Status | Status date | Expires |
|---|---|---|---|---|---|
| CALCIMAGON | 19941672 | 167805 | Registrering opphørt | 2025-05-04 | 2025-05-04 |
| ALBYL-E | 200507321 | 232664 | Registrert | 2006-05-16 | 2036-05-16 |
| DEKADIN | 19560153 | 48818 | Registrert | 1956-09-11 | 2036-09-11 |
| Albyl. | 19120416 | 818 | Registrert | 1912-05-31 | 2032-05-31 |
Source: Patentstyret
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.